Lupin informs about press release

12 Apr 2024 Evaluate

Lupin has informed that it enclosed a Press Release as regards, the successful completion of GMP Inspection by the U.S. FDA, of the Company’s API manufacturing facility located at Dabhasa, India. The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2086.15 5.15 (0.25%)
31-Dec-2025 10:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.00
Dr. Reddys Lab 1262.50
Cipla 1493.45
Zydus Lifesciences 910.15
Lupin 2086.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×